Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from OptiBiotix Health ( (GB:OPTI) ) is now available.
OptiBiotix Health plc has signed a distribution agreement with a prominent weight management company to provide SlimBiome® and WellBiome® products under the distributor’s branding. This partnership aims to leverage the growing interest in non-drug alternatives for weight management, positioning OptiBiotix to integrate its science-backed ingredients into established brands. The agreement is expected to enhance OptiBiotix’s market presence and open new opportunities in the European market.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, is a life sciences company focused on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks. OptiBiotix’s primary areas of focus include obesity, cardiovascular health, and diabetes.
Average Trading Volume: 346,232
Technical Sentiment Signal: Sell
Current Market Cap: £13.43M
Find detailed analytics on OPTI stock on TipRanks’ Stock Analysis page.